The International Vaccine Institute (IVI), the only international organization headquartered in South Korea, appointed Luis Jodar, a former World Health Organization (WHO) employee, as new associate director effective August 19.
Dr. Jodar, a native Spanish citizen who worked with the WHO as scientist for vaccine development for the last six years, will serve as associate director for institutional development, programs and partnerships. Specifically, he will advise the Director of the Institute on overall design of programs, strategies for strengthening the Institute´s capabilities in the vaccine continuum and on resource mobilization activities to broaden the donor support base and financial resources of the Institute.
Earlier in May, the IVI welcomed Aldo Tagliabue, formerly a professor of immunology at the University of Bologna, as deputy director for laboratory sciences. Dr. Tagliabue is responsible for the development of the institute´s laboratory research program at the new IVI headquarters due to be completed in early 2003.
Located at Seoul National University campus, the IVI was firstly initiated in 1997 under the auspices of the United Nations Development Program (UNDP). A not-for-profit International Organisation, the IVI was founded with the aim of improving the health of children in developing countries through the development, introduction and use of new and improved vaccines of public health importance.